Biomaterial Database

[Empiric antibiotic therapy in granulopenic patients]. 1984

J Klastersky

UI	MeSH Term	Description	Entries
D009181	Mycoses	Diseases caused by FUNGI.	Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D009369	Neoplasms	New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380	Agranulocytosis	A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).	Granulocytopenia,Agranulocytoses,Granulocytopenias
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424	Bacterial Infections	Infections by bacteria, general or unspecified.	Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

J Klastersky

Empiric antibiotic therapy for granulocytopenic patients.

November 1982, Bulletin of the New York Academy of Medicine,

J Klastersky

Empiric antibiotic therapy.

May 1978, Cancer treatment reports,

J Klastersky

Empiric antibiotic therapy for granulocytopenic cancer patients.

May 1986, The American journal of medicine,

J Klastersky

Towards individually tailored empiric antibiotic therapy in febrile granulocytopenic patients.

October 1990, The Netherlands journal of medicine,

J Klastersky

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.

August 1979, The American journal of medicine,

J Klastersky

Neutropenia: antibiotic combinations for empiric therapy.

February 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

J Klastersky

Empiric antibiotic therapy after cardiac arrest.

January 2017, Medicina clinica,

J Klastersky

[Acute appendicitis and empiric antibiotic therapy].

January 2010, Chirurgia (Bucharest, Romania : 1990),

J Klastersky

Empiric antibiotic therapy for intraabdominal infections.

January 1983, Reviews of infectious diseases,

J Klastersky

Empiric antibiotic therapy in the neutropenic patient.

February 1988, British journal of clinical practice. Supplement,